Treatment of pseudobulbar affect in ALS.
Smith
Richard A
RA
Center for Neurologic Study, La Jolla, CA, USA.
Brooks
Ben R
BR
D000690:Amyotrophic Lateral Sclerosis / Q000188:drug therapy* / Q000503:physiopathology*; D000818:Animals; D001923:Brain Chemistry / Q000187:drug effects; D003915:Dextromethorphan / Q000008:administration & dosage / Q000009:adverse effects*; D004195:Disease Models, Animal; D004338:Drug Combinations; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018691:Excitatory Amino Acid Antagonists / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D020828:Pseudobulbar Palsy / Q000188:drug therapy* / Q000503:physiopathology*; D011802:Quinidine / Q000627:therapeutic use; D012701:Serotonin / Q000378:metabolism
D004338:Drug Combinations; D004791:Enzyme Inhibitors; D018691:Excitatory Amino Acid Antagonists; D012701:Serotonin; D003915:Dextromethorphan; D011802:Quinidine